Infimer Stock Forecast - Simple Moving Average

INFR Stock  ILA 20,890  15,890  317.80%   
The Simple Moving Average forecasted value of Infimer on the next trading day is expected to be 20,890 with a mean absolute deviation of 3,620 and the sum of the absolute errors of 213,576. Infimer Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Infimer stock prices and determine the direction of Infimer's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Infimer's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A two period moving average forecast for Infimer is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Infimer Simple Moving Average Price Forecast For the 17th of December 2024

Given 90 days horizon, the Simple Moving Average forecasted value of Infimer on the next trading day is expected to be 20,890 with a mean absolute deviation of 3,620, mean absolute percentage error of 53,918,341, and the sum of the absolute errors of 213,576.
Please note that although there have been many attempts to predict Infimer Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Infimer's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Infimer Stock Forecast Pattern

Backtest InfimerInfimer Price PredictionBuy or Sell Advice 

Infimer Forecasted Value

In the context of forecasting Infimer's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Infimer's downside and upside margins for the forecasting period are 20,543 and 21,237, respectively. We have considered Infimer's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
20,890
20,543
Downside
20,890
Expected Value
21,237
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Infimer stock data series using in forecasting. Note that when a statistical model is used to represent Infimer stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria132.2377
BiasArithmetic mean of the errors -529.9932
MADMean absolute deviation3619.939
MAPEMean absolute percentage error1015.7033
SAESum of the absolute errors213576.4
The simple moving average model is conceptually a linear regression of the current value of Infimer price series against current and previous (unobserved) value of Infimer. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Infimer

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Infimer. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1,04420,8902,109,890
Details
Intrinsic
Valuation
LowRealHigh
859.7617,1952,106,195
Details

Other Forecasting Options for Infimer

For every potential investor in Infimer, whether a beginner or expert, Infimer's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Infimer Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Infimer. Basic forecasting techniques help filter out the noise by identifying Infimer's price trends.

Infimer Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Infimer stock to make a market-neutral strategy. Peer analysis of Infimer could also be used in its relative valuation, which is a method of valuing Infimer by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Infimer Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Infimer's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Infimer's current price.

Infimer Market Strength Events

Market strength indicators help investors to evaluate how Infimer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Infimer shares will generate the highest return on investment. By undertsting and applying Infimer stock market strength indicators, traders can identify Infimer entry and exit signals to maximize returns.

Infimer Risk Indicators

The analysis of Infimer's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Infimer's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting infimer stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation126658.16
Semi Deviation10062.72
Standard Deviation327448.49
Variance1.0722251400903E11
Downside Variance3243.45
Semi Variance1.0125840565E8
Expected Short fall(217,513)
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Infimer Stock

Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.